• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

BrainStorm Therapeutics, Inc.

Monday, June 03, 2024
CP
CNS/Neurological
BrainStorm Therapeutics (BST) is a biotech startup dedicated to addressing the urgent global brain disease crisis. We are developing an innovative AI-powered human brain organoid platform to develop groundbreaking therapies that halt, prevent, or reverse synaptic network dysfunction and neurodegeneration. By applying a precision medicine approach focused on human genetics, brain organoids, clinically translatable screening endpoints, advanced data analytics, and network medicine, we are establishing a robust artificial intelligence system that evolves through iterative outcomes of functional genomic and high-throughput drug perturbations of patient-derived brain organoids to guide target identification, patient stratification, target modulation, and therapeutic focus. BST is led by an experienced team of CNS drug developers, brain organoid pioneers, neuroscientists, and data scientists who have collectively advanced 12 programs into the clinic for neurological disorders.
BrainStorm Therapeutics, Inc.
Company Website: https://www.brainstormtherapeutics.org
Lead Product in Development: Familial Parkinson's disease drug discovery platform
Number Of Unlicensed Products (For Which You Are Seeking Partners): 3

Company HQ City

San Diego

Company HQ State

CA

Company HQ Country

United States

CEO/Top Company Official

Robert T. Fremeau, Jr., Ph.D.

Development Phase of Primary Product

Pre-Clinical
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS